—
C+
C+ The full Closelook — membership. Open the C+ overview

Kenvue Inc. (KVUE) — chart, structure and Closelook read

Home› Indices›
Pick a ticker to load its detail page.

Company snapshot — Kenvue Inc.

KVUE in five paragraphs: what it makes and sells, where it sits in the Closelook stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Kenvue is a consumer health company organised into three segments: Self Care, Skin Health and Beauty, and Essential Health. It sells over-the-counter medicines for cough, cold, allergy and pain, along with skin, hair and baby care, oral care, and vitamins, under brands such as Tylenol, Listerine, Neutrogena, Band-Aid and Zyrtec. It operates across North America, Europe, the Middle East, Africa, Asia-Pacific and Latin America, and is based in Summit, New Jersey.
Where it sits in the stack
Kenvue carries no seat in Rubin, our AI build-out index, so it sits outside that stack entirely; it belongs instead to the household and personal products sleeve of the wider consumer-defensive part of our universe.
Who it is priced against
The diary has no formal peer group recorded for Kenvue; the comparison the market draws is with Procter & Gamble, another large household and personal-products company.
Why Closelook tracks it
Kenvue holds a seat in the S&P 500 but carries no Rubin seat and no Closelook score yet; it has not appeared in any diary edition or quote so far.
What the diary watches
The diary watches whether the shares hold or slip further, given the latest chart reading shows the stock trading below both its 50-day and 200-day levels and off its 52-week high.

Kenvue Inc. (KVUE) trades on US exchanges.

Written from the company’s public profile and Closelook’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

Signals for this name

Every Closelook reading that exists for KVUE, from the same nightly bakes the boards use. Research diary readings, not advice.

Who it is priced against Household & Personal Products · United States · 8 names with week and year-to-date

Peer group

Household & Personal Products · United States

This name carries no Closelook score, so its cohort ranks on trend state — distance to the 50- and 200-day averages — never on a score it does not have.

Compared against KVUE on the nightly bakes; the Peers tab ranks the cohort on the Closelook scores where it exists.

Dividends and capital return trailing yield 4.68%, quarterly · last 0.21 USD on 2026-08-12

Dividends and capital return

What KVUE pays out and buys back — distributions read from the price series, money terms from the filings.

  • Trailing 12 months 0.83 USD per share · a 4.68% yield on the 2026-09-18 close 4 distributions, paid quarterly 2026-09-18
  • Change on the year +1.3% against the prior twelve months prior twelve months 0.82 USD per share
  • Last distribution 0.21 USD per share as the price series records it, within days of the ex-date 2026-08-12
  • By calendar year 2023: 0.20 USD (partial) · 2024: 0.81 USD · 2025: 0.83 USD · 2026: 0.63 USD to date first distribution recorded in the three-year window: 2023-11-07

Per-share amounts are derived from the adjusted price series in the listing currency, so dates sit within days of the ex-date; filing figures come from the fundamentals feed for the last reported fiscal year. An investment diary, not a recommendation.

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 50/100 · S&P 500 fund at 49, above its 50- and 200-day averagesEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-18
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 97th percentile of the window, +4.9% over 20 sessions. Factor regime → 2026-09-18
  • Sovereign pressure Index 0.07 · down 0.41 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-18

FAQ · from the current data · as of 2026-09-19

Quick answers

What is Kenvue Inc. (KVUE)?

Kenvue Inc. trades as KVUE on the US exchange (United States) in the Closelook research universe, as of the registry build of 2026-09-19.

Is KVUE in a Closelook index?

Not currently — Kenvue Inc. is tracked in the Closelook research universe but is not a constituent of a Closelook functional index as of 2026-09-19.

Where does KVUE trade against its moving averages?

Mixed moving-average stack: Trades -5.7% vs the 50-day and -0.1% vs the 200-day average, 11.5% below the 52-week high and +31.7% off the 52-week low. Computed from daily closes. As of 2026-09-18 — a technical state from the nightly Closelook bake, not advice. The Technical tab carries the full row.

What does Kenvue Inc. do?

Kenvue is a consumer health company organised into three segments: Self Care, Skin Health and Beauty, and Essential Health. It sells over-the-counter medicines for cough, cold, allergy and pain, along with skin, hair and baby care, oral care, and vitamins, under brands such as Tylenol, Listerine, Neutrogena, Band-Aid and Zyrtec. It operates across North America, Europe, the Middle East, Africa, Asia-Pacific and Latin America, and is based in Summit, New Jersey. The diary has no formal peer group recorded for Kenvue; the comparison the market draws is with Procter & Gamble, another large household and personal-products company.

Where does Kenvue Inc. sit in the AI build-out?

Kenvue carries no seat in Rubin, our AI build-out index, so it sits outside that stack entirely; it belongs instead to the household and personal products sleeve of the wider consumer-defensive part of our universe. Kenvue holds a seat in the S&P 500 but carries no Rubin seat and no Closelook score yet; it has not appeared in any diary edition or quote so far.

Does Kenvue Inc. pay a dividend?

Kenvue Inc. has paid 0.83 USD per share over the last twelve months, paid quarterly, a trailing yield of 4.68% on the 2026-09-18 close; the last distribution recorded in the price series was 0.21 USD on 2026-08-12. The "Dividends and capital return" block on this page carries the lines.

What does this page show?

A live price chart with SMA overlays and drawing tools for KVUE, performance metrics, index-membership context and the Closelook structure read — an investment research diary view, not investment advice.

Related in the Closelook universe

then Household & Personal Products, then Consumer Defensive. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.